{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:30:03Z","timestamp":1793626203666,"version":"4.5.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.10.002","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:09:28Z","timestamp":1791562168000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral or Enteral Levothyroxine for Myxedema Coma When Intravenous Therapy Is Unavailable: A Systematic Review and Descriptive Evidence Synthesis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-5492","authenticated-orcid":false,"given":"Vivek","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mannuru","family":"Venkateswarlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2552-5807","authenticated-orcid":false,"given":"Amal","family":"Shaharyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-8778","authenticated-orcid":false,"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10101","key":"10.1016\/j.eprac.2026.10.002_bib15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eprac.2026.10.002_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.10.002_bib2","series-title":"Endotext. South Dartmouth, MA: MDText.com","article-title":"Myxedema and coma (severe hypothyroidism)","author":"Wiersinga","year":"2018"},{"issue":"4","key":"10.1016\/j.eprac.2026.10.002_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ecl.2006.09.003","article-title":"Myxedema coma","volume":"35","author":"Wartofsky","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.eprac.2026.10.002_bib4","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/493462","article-title":"Myxedema coma: a new look into an old crisis","volume":"2011","author":"Mathew","year":"2011","journal-title":"J Thyroid Res"},{"issue":"8","key":"10.1016\/j.eprac.2026.10.002_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4158\/EP13460.OR","article-title":"A diagnostic scoring system for myxedema coma","volume":"20","author":"Popoveniuc","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.10.002_bib16","series-title":"Levothyroxine Sodium Injection prescribing information","year":"2024"},{"key":"10.1016\/j.eprac.2026.10.002_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.1964.00280070091015","article-title":"Treatment of myxedema coma with intravenous thyroxine","volume":"113","author":"Holvey","year":"1964","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.10.002_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000507855","article-title":"Oral levothyroxine is an effective option for myxedema coma: a single-centre experience","volume":"10","author":"Rajendran","year":"2021","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.eprac.2026.10.002_bib8","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ccr3.1131","article-title":"Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma","volume":"5","author":"Charoensri","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.eprac.2026.10.002_bib9","doi-asserted-by":"crossref","DOI":"10.1530\/EDM-21-0197","article-title":"Initial treatment of myxedema coma using oral levothyroxine: a case report from Tanzania","author":"Chamba","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"10.1016\/j.eprac.2026.10.002_bib10","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf202","article-title":"Oral levothyroxine for myxedema crisis: a case series from a tertiary referral center","volume":"10","author":"Arias-Valderrama","year":"2026","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eprac.2026.10.002_bib19","article-title":"Successful treatment of myxedema coma using levothyroxine and liothyronine in the setting of adrenal crisis and severe cardiogenic shock in a patient with apparent primary empty sella","volume":"22","author":"Elghawy","year":"2021","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"10.1016\/j.eprac.2026.10.002_bib22","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/cc6211","article-title":"Predictors of outcome in myxoedema coma: a study from a tertiary care centre","volume":"12","author":"Dutta","year":"2008","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.eprac.2026.10.002_bib20","article-title":"Hypothyroid crisis: oral or intravenous treatment? A report of two cases","volume":"8","author":"Gadaen","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.10.002_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jpc.15640","article-title":"Is oral levothyroxine as effective as its intravenous form in myxoedema crisis with catecholamine-refractory shock?","volume":"58","author":"Hariharan","year":"2022","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"10.1016\/j.eprac.2026.10.002_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.je.2016.04.002","article-title":"Clinical characteristics and outcomes of myxedema coma: analysis of a national inpatient database in Japan","volume":"27","author":"Ono","year":"2017","journal-title":"J Epidemiol"},{"issue":"12","key":"10.1016\/j.eprac.2026.10.002_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.1999.9.1167","article-title":"Factors associated with mortality of myxedema coma: report of eight cases and literature survey","volume":"9","author":"Yamamoto","year":"1999","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.002_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-8529(18)30166-X","article-title":"Myxedema coma: a form of decompensated hypothyroidism","volume":"22","author":"Nicoloff","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.002_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mcna.2012.01.015","article-title":"Thyroid emergencies","volume":"96","author":"Klubo-Gwiezdzinska","year":"2012","journal-title":"Med Clin North Am"},{"issue":"11","key":"10.1016\/j.eprac.2026.10.002_bib17","first-page":"2485","article-title":"Myxedema coma: diagnosis and treatment","volume":"62","author":"Wall","year":"2000","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.eprac.2026.10.002_bib23","article-title":"Amiodarone-Induced Myxedema coma in elderly patients: a systematic review of case reports","volume":"15","author":"Alnaeem","year":"2023","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.eprac.2026.10.002_bib24","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1210\/clinem\/dgag036","article-title":"Heart ventricular function in hospitalized patients with severe hypothyroidism and myxedema coma","volume":"111","author":"Lado-Abeal","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.10.002_bib18","first-page":"419","article-title":"Clinical features and outcomes of myxedema coma in patients hospitalized for hypothyroidism: analysis of the United States National Inpatient Sample","volume":"34","author":"Chen","year":"2024","journal-title":"Thyroid"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:55:59Z","timestamp":1793624159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26012735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S1530891X26012735"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.10.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral or Enteral Levothyroxine for Myxedema Coma When Intravenous Therapy Is Unavailable: A Systematic Review and Descriptive Evidence Synthesis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}